News and Media

Quantum Genomics announces the establishment of a liquidity contract with Aurel BGC

9 April 2014
|

Quantum Genomics today announced the implementation of a liquidity contract with Aurel BGC.
By contract dated April 7, 2014 with effect as of April 10, 2014, Quantum Genomics entrusted Aurel BGC with the implementation of  a liquidity contract in accordance with the Charter of Ethics established by the […]

Signing of a collaboration agreement with a major company in the field of animal health.

13 February 2014
|

Quantum Genomics, a biopharmaceutical research company developing new treatments in the field of cardiovascular diseases, has announced that it concluded a collabration agreement with a major company in the field of animal health,  for the QGC101 programme. This agreement aims to continue the development of a drug candidate […]

ANR provides a grant of € 1 million for the implementation of a research program with the QGC001

10 January 2014
|

Quantum Genomics, a biopharmaceutical research company developing new treatments in the field of cardiovascular diseases, has announced that the CLINAPAI program coordinated by Quantum Genomics under the scientific supervision of Dr. Catherine Llorens-Cortes (INSERM U1050/Collège of France) and in collaboration with the Clinical Investigation Centre […]

Quantum Genomics announces first results of clinical phase I studies conducted with product QGC001

6 December 2013
|

Quantum Genomics, a biopharmaceutical research company developing new treatments in the field of cardiovascular diseases, announced that it will present the first results of clinical phase I studies conducted with QGC001 its first product, the 20 December 2013 on the occasion of the 33th days of Hypertension […]

‹ Prev page1 2 3 4 5 6 7 8 9 10 11 12 13 14 15